Magnolia Home Health Care, Inc | |
1285 Pine St., Suite 100, Arcadia, Louisiana 71001 | |
(318) 263-2100 | |
Name | Magnolia Home Health Care, Inc |
---|---|
Location | 1285 Pine St., Suite 100, Arcadia, Louisiana |
Certified By | Medicare |
Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Home Health Aide |
Medicare ID | 197447 |
Ownership Type | Proprietary |
Service Area Zip Codes | 71001, 71003, 71008, 71016, 71028, 71038, 71040, 71048, 71055, 71058, 71068, 71070, 71080, 71222, 71226, 71234, 71235, 71241, 71245, 71247, 71251, 71268, 71270, 71275, 71422, 71483 |
NPI Number | 1245348317 |
Organization Name | MAGNOLIA HOME HEALTH CARE, INC. |
Address | 1285 Pine St, Suite 100, Arcadia, LA 71001 |
Phone Number | 318-263-2100 |
News Archive
The COVID-19 pandemic has magnified the social, educational and health care disparities already plaguing the nearly 40 million Americans the U.S. Census Bureau estimates are living in poverty.
It's said that you can judge a man by the quality of his enemies. If the same principle applies to legislation, the Affordable Care Act -; which was signed into law two years ago, but for the most part has yet to take effect -; sits in a place of high honor.
Cordis Corporation has announced the first patient enrollment in the STROLL trial, which will evaluate the safety and efficacy of the S.M.A.R.T. Nitinol Self-Expandable Stent System in treating patients with obstructive superficial femoral artery (SFA) disease, also known as SFA atherosclerosis.
Foresight Diagnostics, the emerging leader in blood-based lymphoma disease monitoring, announced today that clinical performance of its minimal residual disease (MRD) detection platform in diffuse large B-cell lymphoma (DLBCL) will be presented at the 16th International Conference on Malignant Lymphoma (ICML) on June 18-22, 2021.
› Verified 6 days ago
Quality Rating: |
News Archive
The COVID-19 pandemic has magnified the social, educational and health care disparities already plaguing the nearly 40 million Americans the U.S. Census Bureau estimates are living in poverty.
It's said that you can judge a man by the quality of his enemies. If the same principle applies to legislation, the Affordable Care Act -; which was signed into law two years ago, but for the most part has yet to take effect -; sits in a place of high honor.
Cordis Corporation has announced the first patient enrollment in the STROLL trial, which will evaluate the safety and efficacy of the S.M.A.R.T. Nitinol Self-Expandable Stent System in treating patients with obstructive superficial femoral artery (SFA) disease, also known as SFA atherosclerosis.
Foresight Diagnostics, the emerging leader in blood-based lymphoma disease monitoring, announced today that clinical performance of its minimal residual disease (MRD) detection platform in diffuse large B-cell lymphoma (DLBCL) will be presented at the 16th International Conference on Malignant Lymphoma (ICML) on June 18-22, 2021.
› Verified 6 days ago
Quality Measure | Provider | National Avg. |
---|---|---|
How often the home health team began their patients’ care in a timely manner | 93 | 95.7 |
How often the home health team taught patients (or their family caregivers) about their drugs | 96 | 98.6 |
How often the home health team checked patients’ risk of falling | 99.5 | 99.6 |
How often the home health team checked patients for depression | 99.6 | 97.4 |
How often the home health team made sure that their patients have received a flu shot for the current flu season. | 81.9 | 78.7 |
How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 84.7 | 82.2 |
With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | 100 | 96.4 |
News Archive
The COVID-19 pandemic has magnified the social, educational and health care disparities already plaguing the nearly 40 million Americans the U.S. Census Bureau estimates are living in poverty.
It's said that you can judge a man by the quality of his enemies. If the same principle applies to legislation, the Affordable Care Act -; which was signed into law two years ago, but for the most part has yet to take effect -; sits in a place of high honor.
Cordis Corporation has announced the first patient enrollment in the STROLL trial, which will evaluate the safety and efficacy of the S.M.A.R.T. Nitinol Self-Expandable Stent System in treating patients with obstructive superficial femoral artery (SFA) disease, also known as SFA atherosclerosis.
Foresight Diagnostics, the emerging leader in blood-based lymphoma disease monitoring, announced today that clinical performance of its minimal residual disease (MRD) detection platform in diffuse large B-cell lymphoma (DLBCL) will be presented at the 16th International Conference on Malignant Lymphoma (ICML) on June 18-22, 2021.
› Verified 6 days ago
Quality Measure | Provider | National Avg. |
---|---|---|
How often patients got better at walking or moving around | 67.6 | 79.6 |
How often patients got better at getting in and out of bed | 64.7 | 81.1 |
How often patients got better at bathing | 70.7 | 82.3 |
How often patients’ breathing improved | 63.6 | 82.8 |
How often patients’ wounds improved or healed after an operation | - | 92.3 |
How often patients got better at taking their drugs correctly by mouth | 63.6 | 75 |
How often home health patients had to be admitted to the hospital | 16.1 | 15.4 |
How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | 20.7 | 13 |
How often physician-recommended actions to address medication issues were completely timely | 97.7 | 94 |
News Archive
The COVID-19 pandemic has magnified the social, educational and health care disparities already plaguing the nearly 40 million Americans the U.S. Census Bureau estimates are living in poverty.
It's said that you can judge a man by the quality of his enemies. If the same principle applies to legislation, the Affordable Care Act -; which was signed into law two years ago, but for the most part has yet to take effect -; sits in a place of high honor.
Cordis Corporation has announced the first patient enrollment in the STROLL trial, which will evaluate the safety and efficacy of the S.M.A.R.T. Nitinol Self-Expandable Stent System in treating patients with obstructive superficial femoral artery (SFA) disease, also known as SFA atherosclerosis.
Foresight Diagnostics, the emerging leader in blood-based lymphoma disease monitoring, announced today that clinical performance of its minimal residual disease (MRD) detection platform in diffuse large B-cell lymphoma (DLBCL) will be presented at the 16th International Conference on Malignant Lymphoma (ICML) on June 18-22, 2021.
› Verified 6 days ago
Question Type: | Rating by Patients |
---|---|
Health team gave care in a professional way | |
Health team communicated well with them | |
Health team discussed medicines, pain, and home safety | |
How patients rated overall care from agency |
News Archive
The COVID-19 pandemic has magnified the social, educational and health care disparities already plaguing the nearly 40 million Americans the U.S. Census Bureau estimates are living in poverty.
It's said that you can judge a man by the quality of his enemies. If the same principle applies to legislation, the Affordable Care Act -; which was signed into law two years ago, but for the most part has yet to take effect -; sits in a place of high honor.
Cordis Corporation has announced the first patient enrollment in the STROLL trial, which will evaluate the safety and efficacy of the S.M.A.R.T. Nitinol Self-Expandable Stent System in treating patients with obstructive superficial femoral artery (SFA) disease, also known as SFA atherosclerosis.
Foresight Diagnostics, the emerging leader in blood-based lymphoma disease monitoring, announced today that clinical performance of its minimal residual disease (MRD) detection platform in diffuse large B-cell lymphoma (DLBCL) will be presented at the 16th International Conference on Malignant Lymphoma (ICML) on June 18-22, 2021.
› Verified 6 days ago
The patient survey data of Magnolia Home Health Care, Inc is compared against the national average with the color code indicators: Better than National Average Worse than National AverageExperience Measure | Provider | National Avg. |
---|---|---|
Percent of patients who reported that their home health team gave care in a professional way | 88 | 88 |
Percent of patients who reported that their home health team communicated well with them | 91 | 85 |
Percent of patients who reported that their home health team discussed medicines, pain, and home safety with them | 90 | 83 |
Percent of patients who gave their home health agency a rating of 9 or 10 on a scale from 0 (lowest) to 10 (highest) | 90 | 84 |
Percent of patients who reported YES, they would definitely recommend the home health agency to friends and family | 87 | 78 |
News Archive
The COVID-19 pandemic has magnified the social, educational and health care disparities already plaguing the nearly 40 million Americans the U.S. Census Bureau estimates are living in poverty.
It's said that you can judge a man by the quality of his enemies. If the same principle applies to legislation, the Affordable Care Act -; which was signed into law two years ago, but for the most part has yet to take effect -; sits in a place of high honor.
Cordis Corporation has announced the first patient enrollment in the STROLL trial, which will evaluate the safety and efficacy of the S.M.A.R.T. Nitinol Self-Expandable Stent System in treating patients with obstructive superficial femoral artery (SFA) disease, also known as SFA atherosclerosis.
Foresight Diagnostics, the emerging leader in blood-based lymphoma disease monitoring, announced today that clinical performance of its minimal residual disease (MRD) detection platform in diffuse large B-cell lymphoma (DLBCL) will be presented at the 16th International Conference on Malignant Lymphoma (ICML) on June 18-22, 2021.
› Verified 6 days ago
Magnolia Home Health Care, Inc Location: 1285 Pine St., Suite 100, Arcadia, Louisiana 71001 Ratings: Phone: (318) 263-2100 |